In contrast to antagonism of DOR, agonist activation of MOR has also been reported to have salutary activity against AD through several mechanisms (Cui et al., 2011; Wang et al., 2015a; Dhull and Kumar, 2018). Here, OPRD1 is linked to Alzheimer disease.